IN2014CN02188A - - Google Patents

Download PDF

Info

Publication number
IN2014CN02188A
IN2014CN02188A IN2188CHN2014A IN2014CN02188A IN 2014CN02188 A IN2014CN02188 A IN 2014CN02188A IN 2188CHN2014 A IN2188CHN2014 A IN 2188CHN2014A IN 2014CN02188 A IN2014CN02188 A IN 2014CN02188A
Authority
IN
India
Prior art keywords
composition
salt
less
aqueous pharmaceutical
deoxycholic acid
Prior art date
Application number
Other languages
English (en)
Inventor
Robert Emil Hodge
Jeffrey Douglas Webster
Robert M Moriarty
Original Assignee
Kythera Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45569726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014CN02188(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kythera Biopharmaceuticals Inc filed Critical Kythera Biopharmaceuticals Inc
Publication of IN2014CN02188A publication Critical patent/IN2014CN02188A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
IN2188CHN2014 2011-08-23 2011-08-23 IN2014CN02188A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/048806 WO2013028177A1 (en) 2011-08-23 2011-08-23 Formulations of deoxycholic acid and salts thereof

Publications (1)

Publication Number Publication Date
IN2014CN02188A true IN2014CN02188A (pt) 2015-05-29

Family

ID=45569726

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2188CHN2014 IN2014CN02188A (pt) 2011-08-23 2011-08-23

Country Status (18)

Country Link
JP (1) JP5919597B2 (pt)
KR (5) KR102073536B1 (pt)
CN (3) CN108743522A (pt)
AU (3) AU2011375432B2 (pt)
BR (1) BR112014000547B1 (pt)
CA (1) CA2842177C (pt)
CR (1) CR20140053A (pt)
EA (1) EA029305B1 (pt)
IL (1) IL230547A (pt)
IN (1) IN2014CN02188A (pt)
MX (1) MX350390B (pt)
MY (1) MY184277A (pt)
NZ (1) NZ620040A (pt)
PH (1) PH12016501175B1 (pt)
SG (1) SG2014013205A (pt)
UA (1) UA113522C2 (pt)
WO (1) WO2013028177A1 (pt)
ZA (1) ZA201401027B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
KR20180100309A (ko) * 2015-11-04 2018-09-10 키쎄라 바이오파마슈티컬즈 인코포레이티드 데옥시콜산 및 이의 염을 사용한 축적된 지방의 치료 방법
KR101841193B1 (ko) * 2016-09-22 2018-03-22 이경락 저장성 지방 분해 조성물 및 그의 제조 방법
US20180078621A1 (en) * 2016-09-22 2018-03-22 Kyoung Lack Lee Composition for hypotonic lipolysis and manufacturing method thereof
BR112020019192A2 (pt) * 2018-04-16 2021-01-05 Penmix Ltd. Composição farmacêutica que compreende ácido deoxicólico
KR102172439B1 (ko) * 2018-12-05 2020-10-30 송미희 지방 분해용 조성물 및 이를 포함하는 주사제 조성물
KR102064864B1 (ko) 2019-02-08 2020-01-10 (주)제테마 국소 주사용 조성물
KR102111346B1 (ko) 2019-08-20 2020-05-22 아영창 침전으로부터 안정한 소듐디옥시콜레이트를 포함하는 수용액상 조성물
KR20220026068A (ko) 2020-08-25 2022-03-04 강명범 지방 분해용 주사제 조성물
CN116617160A (zh) * 2023-07-25 2023-08-22 山东则正医药技术有限公司 水性混悬液及制备方法、冻干粉及应用、脂肪消减注射剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
JP4790123B2 (ja) * 1998-07-24 2011-10-12 ヨー、セオ、ホン 胆汁酸を有する透明水溶液型製剤の調剤
US6417179B1 (en) * 1998-10-13 2002-07-09 Craig G. Burkhart Ear wax solution
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
DE10361067A1 (de) * 2003-12-22 2005-07-14 Aventis Pharma Deutschland Gmbh Medikamentöse Lipolyse von Fettansammlungen
EP3424508B1 (en) 2004-05-19 2021-05-05 Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Use of sodium deoxycholate for the removal of localized fat accumulation
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20090317376A1 (en) 2005-06-06 2009-12-24 Georgetown University Medical School Compositions And Methods For Lipo Modeling
TW201011755A (en) 2008-09-10 2010-03-16 Skymedi Corp Flash memory system and its data recovery method
JP5420946B2 (ja) * 2009-03-23 2014-02-19 富士フイルム株式会社 胆汁酸を含むミノキシジル水性組成物
EP2645099A1 (en) 2012-03-30 2013-10-02 Phares Pharmaceutical Research N.V. Biorelevant compositions

Also Published As

Publication number Publication date
EA029305B1 (ru) 2018-03-30
JP5919597B2 (ja) 2016-05-18
CA2842177A1 (en) 2013-02-28
KR20170075016A (ko) 2017-06-30
CR20140053A (es) 2014-06-12
IL230547A (en) 2017-02-28
CN108743522A (zh) 2018-11-06
CN103826608A (zh) 2014-05-28
MY184277A (en) 2021-03-30
AU2016202661B2 (en) 2018-02-22
AU2011375432A1 (en) 2014-02-06
AU2018202807B2 (en) 2020-01-16
KR102034606B1 (ko) 2019-10-22
PH12016501175A1 (en) 2017-12-11
KR102073536B1 (ko) 2020-02-04
MX350390B (es) 2017-09-06
WO2013028177A1 (en) 2013-02-28
BR112014000547A2 (pt) 2017-02-14
NZ620040A (en) 2016-06-24
UA113522C2 (xx) 2017-02-10
KR101919269B1 (ko) 2018-11-15
KR20180123734A (ko) 2018-11-19
BR112014000547B1 (pt) 2021-11-09
IL230547A0 (en) 2014-03-31
SG2014013205A (en) 2014-05-29
AU2016202661A1 (en) 2016-05-19
EA201490175A1 (ru) 2014-06-30
MX2014001495A (es) 2014-04-25
AU2011375432B2 (en) 2016-02-04
JP2014524467A (ja) 2014-09-22
AU2018202807A1 (en) 2018-05-10
KR20190119677A (ko) 2019-10-22
ZA201401027B (en) 2017-09-27
PH12016501175B1 (en) 2017-12-11
KR20200013103A (ko) 2020-02-05
KR20150000448A (ko) 2015-01-02
KR101751585B1 (ko) 2017-06-27
CN108619089A (zh) 2018-10-09
CA2842177C (en) 2016-07-19

Similar Documents

Publication Publication Date Title
IN2014CN02188A (pt)
MY160249A (en) Fatty acid fumarate derivatives and their uses
MY176803A (en) Polymorph of syk inhibitors
EP4335507A3 (en) Combination therapy
MX340125B (es) 2-hidroxi-4-(metiltio) butironitrilo estable en almacenamiento.
UA105229C2 (uk) Фармацевтичний склад
MX2016008665A (es) Derivado basado en 1,2-naftoquinona y metodo de preparacion del mismo.
MX2018001145A (es) Métodos para la preparación de ácidos biliares y derivados de los mismos.
MX348831B (es) Administración parenteral de tapentadol.
PH12015501752B1 (en) Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors
MX2013000009A (es) Procedimiento de preparacion de la sal de l-arginina de perindoprilo.
BR112016027760A2 (pt) método de síntese de ph baixo de complexo de zinco-lisina
CY1115372T1 (el) Συνθεσεις δεσοξυχολικου οξεος και αλατα αυτου
CA2922375C (en) Alpha-tea salt forms: compositions and uses for treating disease
BR112014014635A2 (pt) método para fabricar um composto, e, composto
MX2014002448A (es) Reduccion de acidos fosforosos organicos.
PH12017500435A1 (en) A salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof
EA201890018A1 (ru) Композиция для придания формы волосам
PH12018501046A1 (en) Crystals of monovalent cation salt of 3-hydroxyisovaleric acid, and method for producing said crystals
EA201992511A1 (ru) Составы дезоксихолевой кислоты и ее солей
EA201790055A2 (ru) Составы дезоксихолевой кислоты и ее солей
PH12017500167A1 (en) Crystal of alkali metal n-acetylneuraminate anhydrate, and method for producing same
WO2015001565A3 (en) "an improved process for the preparation of 3-aryloxy-3- phenylpropylamine and salt thereof"
WO2015050199A3 (ja) 新規化合物、その製造方法及びその用途
GR1007638B (el) Μεθοδος για την παρασκευη αλατος του 3-(ν-μεθυλ-ν-πεντυλ) αμινο-1-υδροξυπροπανιο-1,1-διφωσφονικου οξεος ή παραγωγων αυτου